MELISA Institute Researchers visit Max Planck Institute and Bruker in Germany

In September, Mauricio Hernández, Researcher Deputy Director and Alan Fritz, Affiliated Researcher, visited the Department of Proteomics and Transduction of Signals at the Instituto Max Planck in Munich, Germany. This laboratory is headed by Dr. Matthias Mann, worldwide leader in development and transfer of new technologies and applications in proteomics. The visit was guided by Dr. Gary Kruppa, Proteomics Vice President in Bruker Daltonics GmbH.

The MELISA delegation participated in theoretical-practical training given by Dr. Romano Hebeler at Bruker’s headquarters in Bremen. This involved advanced techniques in the use of the timsTOF Pro mass spectrometer, proteomics applications with ProteinScape software and analysis of data resulting from mass spectrometry, were some of the points worked. In addition, they participated in an induction to the new timsTOF Flex equipment developed by Bruker, this time given by Dr. Janina Oetjen.

All these activities are carried out within the framework of the Collaboration Agreement between MELISA Institute and Bruker Daltonics GmbH. Consequently, our institution is a pioneer in Latin America, gathering equipment of these characteristics that allows the implementation of high definition techniques. The timsTOF Pro mass spectrometer is one of the best pieces of equipment in protein analysis and mass spectrometry. It is highly decisive in the identification of peptides, as well as in quantification using isotopic/isobaric or free (Free Label) marking.

MELISA focuses the research efforts in three main areas: Public health and epidemiology, prenatal medicine, basic sciences and proteogenomics. In each one of them, our specialists develop research programs.